- Home
- OABI vs OSUR Comparison
OABI vs OSUR Comparison
Compare OABI & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- OSUR
- Stock Information
- Founded
- OABI 2012
- OSUR 2000
- Country
- OABI United States
- OSUR United States
- Employees
- OABI 114
- OSUR N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- OSUR Medical/Dental Instruments
- Sector
- OABI Health Care
- OSUR Health Care
- Exchange
- OABI Nasdaq
- OSUR Nasdaq
- Market Cap
- OABI 239.0M
- OSUR 231.1M
- IPO Year
- OABI N/A
- OSUR 1986
- Fundamental
- Price
- OABI $1.65
- OSUR $2.88
- Analyst Decision
- OABI Strong Buy
- OSUR Hold
- Analyst Count
- OABI 3
- OSUR 1
- Target Price
- OABI $6.67
- OSUR $3.00
- AVG Volume (30 Days)
- OABI 525.9K
- OSUR 464.0K
- Earning Date
- OABI 11-04-2025
- OSUR 11-07-2025
- Dividend Yield
- OABI N/A
- OSUR N/A
- EPS Growth
- OABI N/A
- OSUR N/A
- EPS
- OABI N/A
- OSUR N/A
- Revenue
- OABI $23,027,000.00
- OSUR $138,533,000.00
- Revenue This Year
- OABI N/A
- OSUR N/A
- Revenue Next Year
- OABI $48.74
- OSUR $4.32
- P/E Ratio
- OABI N/A
- OSUR N/A
- Revenue Growth
- OABI 6.05
- OSUR N/A
- 52 Week Low
- OABI $1.22
- OSUR $2.36
- 52 Week High
- OABI $4.87
- OSUR $4.60
- Technical
- Relative Strength Index (RSI)
- OABI 48.14
- OSUR 35.74
- Support Level
- OABI $1.64
- OSUR $2.94
- Resistance Level
- OABI $1.76
- OSUR $3.14
- Average True Range (ATR)
- OABI 0.10
- OSUR 0.11
- MACD
- OABI 0.01
- OSUR -0.02
- Stochastic Oscillator
- OABI 23.44
- OSUR 0.00
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.